Article Sidebar

PDF
Date Published: 12/06/2023
Online Published: 12/06/2023
Abstract Views: 131
Views PDF: 263
Issue
No. 26 (2020)
Section
Article
How to Cite
Nguyen , Q. B., & Luu, T. T. D. (2023). THE VALUE OF IOTA AND ROMA INDEX IN PREDICTING THE RISK OF MALIGNANCY IN OVARIAN TUMORS. Cantho Journal of Medicine and Pharmacy, 26, 41-47. https://tapchi.ctump.edu.vn/index.php/ctump/article/view/1695

THE VALUE OF IOTA AND ROMA INDEX IN PREDICTING THE RISK OF MALIGNANCY IN OVARIAN TUMORS

Quoc Bao Nguyen 1,, Thi Thanh Dao Luu1
1 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

  Background: Ovarian tumor is a very common disease in women, at risk of malignancy. This study helps to determine the value of ROMA and IOTA in predicting the risk of malignancy in ovarian tumors before surgery.Objectives: Identify and compare the values of ROMA and IOTA in predicting malignancy risk of ovarian tumors in Can Tho. Materials and methods: Crosssectional descriptive studies on 207 cases of ovarian tumors underwent surgery at Can Tho Hospital of Maternity in 2017 - 2019. Results: the sensitivity of ROMA is 76.7%. The specificity of ROMA is 96.6%. The positive predictive value of ROMA is 79.3%. The negative predictive value of ROMA is 96.1%. the sensitivity of IOTA SR is 63.3%. The specificity of IOTA SR 94.9%. The positive predictive value of IOTA SR is 82.6%. The negative predictive value of IOTA SR is 98.8%. The sensitivity of IOTA LR2 is 76.7%.The specificity of IOTA LR2 is 97.2%. The positive predictive value of IOTA LR2 is 82.1%. The negative predictive value of IOTA LR2 is 96.1%. Conclusion: IOTA and ROMA are two highly valuable tools for predicting the risk of malignant tumors before surgery.

Article Details

Keywords

Ovarian tumor, ovarian cancer, malignant, IOTA, ROMA, HE4, ultrasound

References

1. Phạm Thị Diệu Hà (2013), "Nhận xét giá trị HE4 và test ROMA trong chẩn đoán ung thư buồng trứng", Tạp Chí Nghiên Cứu Y Học. 82(2), tr. 37-39.
2. Đặng Huy Hoàng (2016), "Nghiên cứu mối tương quan giữa thuật toán ROMA với các đặc điểm giải phẫu bệnh và giai đoạn bệnh trong ung thư buồng trứng", Y Dược Học.
6(1), tr. 48.
3. Võ Văn Khoa (2017), "Nghiên cứu giá trị của HE4, CA125, thuật toán nguy cơ ác tính buồng trứng (ROMA) trong chẩn đoán trước mổ ung thư buồng trứng", Tạp Chí Phụ
Sản. 16(2), tr. 12.
4. Lương Kim Phượng và Nguyễn Hữu Dự (2018), Giá trị siêu âm trong dự đoán u ác buồng trứng theo phân loại IOTA, Hội nghị Sản phụ khoa Đồng bằng sông Cửu Long, Cần Thơ, tr. 212-214.
5. Jacques S Abramowicz và Dirk Timmerman (2017), "Ovarian mass–differentiating benign from malignant: the value of the International Ovarian Tumor Analysis ultrasound rules", American journal of obstetrics and gynecology. 217(6), tr. 652-660.
6. Zinatossadat Bouzari và các cộng sự. (2019), "Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer", International Journal of Cancer Management. 12(1).
7. Jillian T Henderson, Elizabeth M Webber và George F Sawaya (2018), "Screening for ovarian cancer: updated evidence report and systematic review for the US preventive services task force", Jama. 319(6), tr. 595-606.
8. Dirk Timmerman và các cộng sự. (2016), "Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group", American journal of obstetrics and gynecology. 214(4), tr. 424-437.
9. Lindsey A Torre và các cộng sự. (2018), "Ovarian cancer statistics, 2018", CA: a cancer journal for clinicians. 68(4), tr. 284-296.